Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Sales | 5,650 | 4,150 | 4,450 |
| Cost of Goods | 750 | 680 | 0 |
| Gross Profit | 4,900 | 3,460 | 4,450 |
| Operating Expenses | 18,680 | 10,950 | 8,170 |
| Operating Income | -13,030 | -6,800 | -3,720 |
| Other Income | 14,620 | 4,150 | 1,070 |
| Pre-tax Income | 1,590 | -2,650 | -2,650 |
| Net Income Continuous | 660 | -2,650 | -2,650 |
| Net Income | $660 | $-2,650 | $-2,650 |
| EBITDA(a) | $-12,060 | $-6,110 | $-3,390 |